SCHEMBL24696389

SCHEMBL24696389

CCC(CC)c1cc(CC2CCCCCC2)nc2cc(C(=O)N3CCCCC3(C)C)nn12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 6/20 0.36
▸ HPGD P15428 6/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ LMNA P02545 3/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ HTT P42858 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ GAA P10253 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HTR6 P50406 2/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24696219 0.99 CNR2 (0.36) CNR2HPGDALDH1A1KDM4ELMNA
SCHEMBL24696057 0.93 CNR2 (0.36) CNR2HPGDALDH1A1KDM4ELMNA
SCHEMBL24695773 0.92 CNR2 (0.37) CNR2HPGDALDH1A1KDM4ELMNA
SCHEMBL24696160 0.91 CNR2 (0.37) CNR2HPGDALDH1A1KDM4ELMNA
SCHEMBL24696221 0.90 CNR2 (0.38) CNR2HPGDALDH1A1KDM4ELMNA
SCHEMBL24695772 0.88 CNR2 (0.37) CNR2HPGDALDH1A1KDM4ELMNA
SCHEMBL24695593 0.87 HPGD (0.44) HPGDALDH1A1KDM4ELMNANPSR1
SCHEMBL24695675 0.87 HPGD (0.44) HPGDALDH1A1KDM4ELMNANPSR1
SCHEMBL24696335 0.87 HPGD (0.44) HPGDALDH1A1KDM4ELMNANPSR1
SCHEMBL24696157 0.87 HPGD (0.44) HPGDALDH1A1KDM4ELMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022255408-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-12-08 — — WO disclosed
Send feedback